EXEL Exelixis, Inc.
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official
Market Value*
$9.40B
Revenue (FY)
$2.32B 2026-01-02
Net Income (FY)
$782.57M
P/E (float-based)
12.0
Biological Products, (No Diagnostic Substances) · Nasdaq · SEC EDGAR official